Received Jul 3, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MNQ | MENINGOCOCCAL CONJUGATE (MENVEO) | NOVARTIS VACCINES AND DIAGNOSTICS | UNK | 9X7CD | — |
Menveo administration after temperature excursion; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of incorrect storage of drug in a 16-year-old male patient who received Men ACWY-CRM NVS (Menveo) (batch number 9X7CD, expiry date 31-JAN-2026) for prophylaxis. On 19-JUN-2025, the patient received Menveo. On an unknown date, an unknown time after receiving Menveo, the patient experienced incorrect storage of drug (Verbatim: Menveo administration after temperature excursion). The outcome of the incorrect storage of drug was not applicable. Additional Information: GSK receipt date: 24-JUN-2025 Th pharmacist called to verify if doses of vaccines that have been exposed to low temperatures should be repeated. The patient was given the vaccine after temperature excursion which led to incorrect storage of drug. This was 1 of the 6 linked cases reported by the same reporter.; Sender's Comments: US-GSK-US2025079376:Same reporter different patient US-GSK-US2025079384:Same reporter different patient US-GSK-US2025079381:Same reporter different patient US-GSK-US2025079375:Same reporter different patient US-GSK-US2025079387:Same reporter different patient